Related Experiment Videos
Transforming growth factor-beta 1 expression in irradiated liver
M S Anscher1, I R Crocker, R L Jirtle
1Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710.
Radiation Research
|April 1, 1990
Summary
Radiation exposure increases liver transforming growth factor-beta 1 (TGF-beta 1) in rats, promoting fibrosis. Higher TGF-beta 1 in human liver may explain human susceptibility to radiation hepatitis.
Area of Science:
- Hepatology
- Radiation Oncology
- Fibrosis Research
Background:
- Radiation hepatitis is a significant clinical concern following radiotherapy.
- The specific molecular mechanisms driving radiation-induced liver fibrosis remain incompletely understood.
Purpose of the Study:
- To investigate the role of transforming growth factor-beta 1 (TGF-beta 1) in the pathogenesis of radiation-induced liver injury.
- To compare TGF-beta 1 levels in rat and human hepatocytes.
Main Methods:
- Irradiated rats were analyzed 9 months post-exposure for hepatic TGF-beta 1 expression.
- Localized TGF-beta 1 injections were performed in normal rat livers.
- TGF-beta 1 concentrations were measured in rat and human hepatocytes.
Main Results:
- Hepatic TGF-beta 1 expression increased dose-dependently in irradiated rats.
- TGF-beta 1 expression was localized to pericentral hepatocytes and correlated with fibrosis.
- Induced liver fibrosis was observed at TGF-beta 1 injection sites.
- Human hepatocytes exhibited higher basal TGF-beta 1 levels than rat hepatocytes.
Conclusions:
- Increased hepatic TGF-beta 1 is implicated in the development of radiation hepatitis.
- Elevated baseline TGF-beta 1 in human liver may contribute to a higher susceptibility to radiation hepatitis.